Seeking Alpha
Profile| Send Message|
( followers)  

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday July 30.

Bullish Calls:

  • Regeneron (NASDAQ:REGN), Celgene (NASDAQ:CELG), Biogen Idec (NASDAQ:BIIB), Gilead (NASDAQ:GILD), Seattle Genetics (NASDAQ:SGEN), Isis Pharmaceuticals (NASDAQ:ISIS): "In biotech, I like Regeneron, Celgene, Biogen Idec and Gilead. I also like Seattle Genetics and Isis Pharmaceuticals."
  • EMC (NYSE:EMC): "Long term, it might be okay. Now, I'm not crazy about it, but because of saber rattling, it is going higher."
  • Pitney Bowes (NYSE:PBI): "It has moved so much, but those guys are smart, they are doing a lot of great things. It can go higher."
  • Thermo Fisher Scientific (NYSE:TMO): "That was a good quarter, and you did well in that. I urge you to stay with this."
  • DexCom (NASDAQ:DXCM), Edwards Lifesciences (NYSE:EW), St. Jude Medical (NYSE:STJ): "We had DexCom on. I like that company. I think someone might want to buy it. I like Edwards Lifesciences and St. Jude. DexCom is a great spec, but Edwards is best in show."
  • Priceline (NASDAQ:PCLN): "We don't care about the split. Splits have helped some stocks, but you want this one for the earnings."

Bearish Calls:

  • GT Advanced Technologies (GTAT): "This stock is going the wrong way."
  • Arena Pharmaceuticals (NASDAQ:ARNA): "I'm not a fan of it. People got mad at me because of that, but the stock is down."
  • Seadrill (NYSE:SDRL): "This is really a conundrum, because I believe the yield is safe, but there is weakness in the platform business. You may pick up the yield, but you are not going to get upside in the stock."

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.

Source: Cramer's Lightning Round - 6 Biotech Picks (7/30/14)